CAS: 608137-33-3 - Lisdexamfetamine Dimesylate
Formula:C15H25N3O.2CH4O3S
InChI:InChI=1S/C15H25N3O.CH4O3S/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16;1-5(2,3)4/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19);1H3,(H,2,3,4)/t12-,14-;/m0./s1
InChI key:InChIKey=KZHOHVKYLXWNQP-KYSPHBLOSA-N
SMILES:O=C(NC(C)CC=1C=CC=CC1)C(N)CCCCN.O=S(=O)(O)C
- Synonyms:
- Hexanamide, 2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)-, dimethanesulfonate
- Hexanamide, 2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)-, methanesulfonate (1:2)
- LDX
- Lis-dexamfetamine dimesylate
- Lisdexamfetamine mesilate
- Lisdexamfetamine mesylate
- Lisdexamphetamine dimesylate
- N-(<span class="text-smallcaps">L</smallcap>-Lysyl)-<smallcap>D</span>-amphetamine dimesylate
- Nrp 104
- Spd 489
- See more synonyms
- Spd489
- Unii-Sjt761Gegs
- Vyvanse
Lisdexamphetamine Dimesylate
Controlled ProductCAS:608137-33-3
Applications Lisdexamphetamine Dimesylate is used as a treatment for adults with attention-deficit/hyperactivity disorder (ADHD). Lisdexamphetamine …
Formula:
C17H33N3O7S2
Color and Shape:
Neat
Molecular weight:
455.59
Ref: TR-L468885
10mg | 321.00 € | |
100mg | 2,066.00 € |
Estimated delivery in United States, on Friday 31 May 2024
Lisdexamfetamine dimesylate
Controlled ProductCAS:608137-33-3
Dopamine uptake inhibitor; treats ADHD
Formula:
C15H25N3O·2CH4O3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
455.59 g/mol
Ref: 3D-FL162437
1mg | 136.00 € | |
2mg | 204.00 € | |
5mg | 430.00 € | |
10mg | 722.00 € | |
25mg | 1,371.00 € |
Estimated delivery in United States, on Monday 3 Jun 2024
Lisdexamphetamine-d3 Dimesylate (1mg/ml (as free base) in Methanol)
Formula:
C17H30D3N3O7S2
Color and Shape:
Single Solution
Molecular weight:
362.5
Ref: TR-KIT1810
5x1ml | 9,017.00 € |
Estimated delivery in United States, on Monday 1 Jul 2024
Lisdexamphetamine Dimesylate (1mg/ml in Methanol)
CAS:608137-33-3
Formula:
C17H33N3O7S2
Color and Shape:
Single Solution
Molecular weight:
455.59
Ref: TR-KIT2550
1x1ml | 1,044.00 € |
Estimated delivery in United States, on Monday 1 Jul 2024